Pre-course Session: Investigational Medicinal Products (IMP) QP Education Course
Im Auftrag der European QP Association

Pre-course Session: Investigational Medicinal Products (IMP) QP Education Course Im Auftrag der European QP Association

Prague, Czech Republic

Seminar Nr. 16684


Kosten

Non-EQPA/Non-ECA Members: EUR 990,--
EQPA/ECA Members: EUR 890,--
EU GMP Inspectorates: EUR 495,--

Alle Preise zzgl. MwSt.

Rückfragen unter:
Tel.: 06221 / 84 44 0 E-Mail: info@concept-heidelberg.de

Sprecher

Dr Susanne Ding, Boehringer Ingelheim, Germany

Sue Mann, Sue Mann Consultancy, U.K.

Brenda Van Assche, Janssen, Belgium

Zielsetzung

This pre-course session provides a detailed overview of the specific characteristics in IMP manufacturing a QP must know to certify IMP batches for the release for clinical trials.

Hintergrund

The manufacture of investigational medicinal products (IMPs), including labelling, packaging, testing and certification, is carried out in accordance with the applicable GMP regulations. However, this is not a routine process, since, among other things, manufacturing and packaging procedures might be different for each and every clinical trial.

The Qualified Person (QP) must therefore take into account these particularities and the GMP/GCP interface.

Zielgruppe

New colleagues becoming IMP QPs, QPs looking for continuous training and personnel of CROs and “non-commercial” IMP organisations.

Programm

General introduction

  • Different clinical phases I to IV, focus on patient safety
  • Undefined processes (manufacture, fit for purpose control strategy, etc.)
  • Why use risk assessments & how to apply – vital core
  • of a IMP quality system
  • Diversity: IMP manufacturers, start-ups, academia…
Specific legal requirements for IMPs
  • Clinical Trial Regulation EU No. 536/2014 and the “old” Annex 13 and Directives 2001/20/EC and 2003/94/C
  • The “new” ATMP regulation
GMP meets clinical trials – Differences between IMPs and commercial Products
  • Packaging & labeling
  • Randomization
  • Blinding / placebos
  • Comparators
  • NIMPs / AMPs
  • Where to apply validation activities
  • The Product Specification File (PSF)
  • 3rd country manufacture of IMPs: import and the QP Declaration
Registration
  • IMPD, CTA, IND etc.
  • Regulatory compliance and the two step release procedure
GMP meets GCP
  • Interaction with clinical sites
  • Distribution
  • IRT

Zurück

GMP Seminare nach Thema

Cookies helfen uns bei der Bereitstellung unserer Dienste. Durch die Nutzung unserer Dienste erklären Sie sich damit einverstanden, dass wir Cookies setzen. Weitere Informationen

OK